Donor lymphocyte infusion, both alone and in combination with azacitidine, restored CD34 levels in two-thirds of patients ...

Speakers at the European Respiratory Society Congress 2024 provided updates to the 2 trials focusing on depemokimab for ...

Spouses and first-degree relatives of patients with genitourinary (GU) cancers face increased risks of developing ...

Anna Baramidze, MD, PhD, Todua Clinic, Tbilisi, Georgia, details exciting findings from the EMPOWER-Lung 1 trial regarding cemiplimab and patients with non–small cell lung cancer (NSCLC).

During the Delta wave of COVID-19, higher caseload strain negatively impacted patient survival rates across US hospitals, regardless of their size or resources.

Research presented at the 2024 European Society of Cardiology Congress explored gender-based care and outcomes disparities, ...

Lung cancer screening experts from around the globe delivered strategies and best practices for improving access to screening ...

New findings highlight the potential role of artificial intelligence (AI) in supporting health care professionals, but ...

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our ...

Data presented in the second Presidential Symposium at the 2024 World Conference on Lung Cancer showed encouraging responses to novel agents among patients with HER2-mutated non–small cell lung cancer ...

The therapeutic landscape for non–small cell lung cancer (NSCLC) has been relatively stable since the 2016 approval of ...

A panel of experts examines the impact of cardiometabolic diseases in the United States, focusing on their burden, prevalence, and relationship to obesity.